Source:http://linkedlifedata.com/resource/pubmed/id/18260168
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-8
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0315-162X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
359-60
|
pubmed:meshHeading |
pubmed-meshheading:18260168-Adult,
pubmed-meshheading:18260168-CD4-Positive T-Lymphocytes,
pubmed-meshheading:18260168-CD40 Ligand,
pubmed-meshheading:18260168-Coronary Artery Disease,
pubmed-meshheading:18260168-Humans,
pubmed-meshheading:18260168-Lupus Erythematosus, Systemic,
pubmed-meshheading:18260168-Middle Aged
|
pubmed:year |
2008
|
pubmed:articleTitle |
Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus.
|
pubmed:publicationType |
Letter,
Comment
|